DaTSCAN TM 123 I-Ioflupane (INN)

DaTSCAN TM 123 I-Ioflupane (INN) is a medicine authorised by Swissmedic under authorisation number 55717. The authorisation holder is GE Healthcare AG. The medicinal product code is Radiopharmaceuticals and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 June 2001 and the authorisation is valid without a time limit. ATC code V09AB03 places the medicine in the group Diagnostic radiopharmaceuticals.

  • Dispensing category A
  • Authorisation number 55717
  • ATC V09AB03
  • Radiopharmaceuticals
Authorisation data
Authorisation number55717
NameDaTSCAN TM 123 I-Ioflupane (INN)
Full nameDaTSCAN TM 123 I-Ioflupane (INN), Injektionslösung
Authorisation holderGE Healthcare AG
Medicinal product codeRadiopharmaceuticals
Dispensing categoryA · Prescription, not repeatable
ATC codeV09AB03
First authorisation25 June 2001
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1DaTSCAN TM 123 I-Ioflupane (INN), InjektionslösungA25 June 2001

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
22,5mlV09AB0317.01.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is DaTSCAN TM 123 I-Ioflupane (INN) authorised in Switzerland?

Yes. DaTSCAN TM 123 I-Ioflupane (INN) is authorised by Swissmedic under authorisation number 55717, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does DaTSCAN TM 123 I-Ioflupane (INN) have?

DaTSCAN TM 123 I-Ioflupane (INN) is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of DaTSCAN TM 123 I-Ioflupane (INN)?

The authorisation holder is GE Healthcare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com